Global Alpha Capital Management Ltd. Pacira Bio Sciences, Inc. Transaction History
Global Alpha Capital Management Ltd.
- $1.63 Billion
- Q2 2025
A detailed history of Global Alpha Capital Management Ltd. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Global Alpha Capital Management Ltd. holds 79,460 shares of PCRX stock, worth $1.89 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
79,460
Previous 57,086
39.19%
Holding current value
$1.89 Million
Previous $1.42 Million
33.92%
% of portfolio
0.12%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding PCRX
# of Institutions
258Shares Held
51MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$190 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$125 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$53.8 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$53.3 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$48.7 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.09B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...